← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2021Last known activity
Oct 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 6 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Recent trials (9)
- NCT07155265Lead sponsorPhase 3Oct 1, 2025
- NCT07155265Sponsor investigatorPhase 3Oct 1, 2025
- NCT06254690CollaboratorPhase 2Jan 1, 2024
- NCT06232694CollaboratorN/AJan 1, 2024
- NCT05909293CollaboratorN/AApr 12, 2023
- NCT05522582Lead sponsorPhase 2Nov 15, 2021
- NCT05522582Study directorPhase 2Nov 15, 2021
- NCT05522582Reponsible party - principal investigatorPhase 2Nov 15, 2021
- NCT05264883CollaboratorPhase 3Mar 1, 2021
Details
- Last known activity
- Oct 1, 2025